株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓カテーテル:パイプライン分析

Cardiac Catheters - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 345367
出版日 ページ情報 英文 252 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
心臓カテーテル:パイプライン分析 Cardiac Catheters - Medical Devices Pipeline Assessment, 2016
出版日: 2016年12月01日 ページ情報: 英文 252 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている心臓カテーテルのパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を盛り込んでいます。

第1章 目次

第2章 イントロダクション

  • 心臓カテーテルの概要

第3章 開発中の製品

  • 心臓カテーテル - 開発段階別のパイプライン製品
  • 心臓カテーテル - セグメント別のパイプライン製品
  • 心臓カテーテル - 国 (地域) 別のパイプライン製品
  • 心臓カテーテル - 規制別のパイプライン製品
  • 心臓カテーテル - 認証時期別 (推定) のパイプライン製品
  • 心臓カテーテル - 現在進行中の治験

第4章 心臓カテーテル - 開発中のパイプライン製品:企業別

  • 心臓カテーテル企業 - 開発段階別のパイプライン製品
  • 心臓カテーテル - 開発段階別のパイプライン製品

第5章 心臓カテーテル企業と製品の概要

  • AccuTherm Systems, Inc.
  • Andain, Inc
  • AngioDynamics, Inc.
  • Balch Hill Medical Group
  • Bioheart, Inc.
  • Boston Scientific Corporation
  • Boston TransTec, LLC
  • Cardiac Output Technologies, Inc.
  • Cardiovascular Systems, Inc.
  • Cordis Corporation
  • CorNova, Inc.
  • Delft University of Technology
  • Deliverance Ltd.
  • EndoCross Ltd.
  • EP Limited
  • Hadasit Medical Research Services & Development Ltd
  • Harvard University
  • MaRVis Technologies GmbH
  • Mayo Clinic
  • Medeon Biodesign, Inc.
  • Medical Device Investments, Inc.
  • Medikit Co., Ltd.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Neovasc Inc.
  • Nesstent Ltd.
  • NeuroInterventional Therapeutics, Inc.
  • Northwestern University
  • Perseus Biomed Ltd.
  • Pi-Cardia Ltd
  • Pryor Medical Devices, Inc.
  • QualiMed Innovative Medizinprodukte GmbH
  • Rhythm Solutions
  • Therix Medical, Inc.
  • Topspin Medical Inc.
  • TransCardiac Therapeutics, LLC
  • Universite de Montreal
  • University of California, San Francisco
  • University of Limerick
  • Volcano Corporation
  • Voyage Medical

第6章 心臓カテーテル - 最近の動向

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0272EPD

GlobalData's Medical Devices sector report, "Cardiac Catheters - Medical Devices Pipeline Assessment, 2016" provides an overview of Cardiac Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 13

2 Introduction 14

  • 2.1 Cardiac Catheters Overview 14

3 Products under Development 15

  • 3.1 Cardiac Catheters - Pipeline Products by Stage of Development 15
  • 3.2 Cardiac Catheters - Pipeline Products by Segment 16
  • 3.3 Cardiac Catheters - Pipeline Products by Territory 17
  • 3.4 Cardiac Catheters - Pipeline Products by Regulatory Path 18
  • 3.5 Cardiac Catheters - Pipeline Products by Estimated Approval Date 19
  • 3.6 Cardiac Catheters - Ongoing Clinical Trials 20

4 Cardiac Catheters - Pipeline Products under Development by Companies 21

  • 4.1 Cardiac Catheters Companies - Pipeline Products by Stage of Development 21
  • 4.2 Cardiac Catheters - Pipeline Products by Stage of Development 23

5 Cardiac Catheters Companies and Product Overview 25

  • 5.1 3DT Holdings, LLC Company Overview 25
    • 5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.2 AccuTherm Systems, Inc. Company Overview 26
    • 5.2.1 AccuTherm Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.3 Andain, Inc Company Overview 27
    • 5.3.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.4 AngioDynamics Inc Company Overview 28
    • 5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.5 Avantec Vascular Corporation Company Overview 30
    • 5.5.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Balch Hill Medical Group Company Overview 31
    • 5.6.1 Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.7 Boston Scientific Corp Company Overview 32
    • 5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.8 Boston TransTec LLC Company Overview 34
    • 5.8.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.9 Cardiac Output Technologies, Inc. Company Overview 35
    • 5.9.1 Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.10 Cardiovascular Systems Inc Company Overview 36
    • 5.10.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.11 Cordis Corp Company Overview 41
    • 5.11.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.12 CorNova, Inc. Company Overview 44
    • 5.12.1 CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.13 Delft University of Technology Company Overview 47
    • 5.13.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.14 Deliverance Ltd. Company Overview 49
    • 5.14.1 Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.15 EndoCross Ltd. Company Overview 50
    • 5.15.1 EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.16 EP Limited Company Overview 53
    • 5.16.1 EP Limited Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.17 Georgia Institute of Technology Company Overview 54
    • 5.17.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.18 Hadasit Medical Research Services & Development Ltd Company Overview 56
    • 5.18.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.19 Harvard University Company Overview 57
    • 5.19.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.20 MaRVis Technologies GmbH Company Overview 59
    • 5.20.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.21 Mayo Clinic Company Overview 60
    • 5.21.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.22 Mayo Clinic US Company Overview 61
    • 5.22.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.23 Medeon Biodesign, Inc. Company Overview 62
    • 5.23.1 Medeon Biodesign, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.24 Medical Device Investments, Inc. Company Overview 63
    • 5.24.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.25 Medikit Co Ltd Company Overview 65
    • 5.25.1 Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.26 Medtronic plc Company Overview 68
    • 5.26.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.27 Merit Medical Systems, Inc. Company Overview 70
    • 5.27.1 Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.28 MicroPort Scientific Corporation Company Overview 72
    • 5.28.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.29 Neovasc Inc Company Overview 74
    • 5.29.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.30 Nesstent Ltd. Company Overview 75
    • 5.30.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.31 NeuroInterventional Therapeutics, Inc. Company Overview 76
    • 5.31.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.32 Northwestern University Company Overview 78
    • 5.32.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.33 Perseus Biomed Ltd. Company Overview 79
    • 5.33.1 Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.34 Pi-Cardia Ltd Company Overview 80
    • 5.34.1 Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.35 QualiMed Innovative Medizinprodukte GmbH Company Overview 82
    • 5.35.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.36 Rhythm Solutions Company Overview 83
    • 5.36.1 Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.37 Sonix Therapeutics Company Overview 84
    • 5.37.1 Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 84
  • 5.38 Therix Medical, Inc. Company Overview 85
    • 5.38.1 Therix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.39 Topspin Medical Inc. Company Overview 86
    • 5.39.1 Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.40 TransCardiac Therapeutics, LLC Company Overview 88
    • 5.40.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.41 U.S. Stem Cell Inc Company Overview 89
    • 5.41.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.42 Universite de Montreal Company Overview 91
    • 5.42.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.43 University of California San Francisco Company Overview 92
    • 5.43.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.44 University of Limerick Company Overview 94
    • 5.44.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.45 University of Michigan Company Overview 95
    • 5.45.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.46 Volcano Corp Company Overview 96
    • 5.46.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.47 Voyage Medical (Inactive) Company Overview 97
    • 5.47.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.48 Weill Cornell Medical College Company Overview 98
    • 5.48.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 98

6 Cardiac Catheters- Recent Developments 99

  • 6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 99
  • 6.2 Nov 18, 2016: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion 101
  • 6.3 Nov 18, 2016: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion 102
  • 6.4 Nov 18, 2016: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion 102
  • 6.5 Nov 18, 2016: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion 103
  • 6.6 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion 103
  • 6.7 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion 103
  • 6.8 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 104
  • 6.9 Nov 15, 2016: Interim Report Vigmed Holding January - September 2016 104
  • 6.10 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million 105
  • 6.11 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 105
  • 6.12 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 107
  • 6.13 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 108
  • 6.14 Nov 04, 2016: AngioSoma to Upgrade Its OmniCath Patents into OmniCath 2 Atherectomy Catheter 108
  • 6.15 Nov 03, 2016: Mattias Perjos appointed President and CEO of Getinge Group 109
  • 6.16 Nov 01, 2016: Endologix Reports Results for the Third Quarter 2016 109
  • 6.17 Oct 31, 2016: Guided Delivery Systems Announces Senior Leaders and Company Name Change to Ancora Heart 111
  • 6.18 Oct 27, 2016: Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year 111
  • 6.19 Oct 27, 2016: Stryker reports third quarter 2016 results 112
  • 6.20 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 113
  • 6.21 Oct 27, 2016: Amedisys Previews Third Quarter 2016 Results 115
  • 6.22 Oct 27, 2016: Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million 116
  • 6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 116
  • 6.24 Oct 26, 2016: Cardiovascular Systems Reports Fiscal 2017 First-Quarter Financial Results 118
  • 6.25 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 119
  • 6.26 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 120
  • 6.27 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 120
  • 6.28 Oct 25, 2016: Endologix Appoints Matthew Thompson, M.D., as Chief Medical Officer 121
  • 6.29 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 122
  • 6.30 Oct 25, 2016: Bard Announces Third Quarter Results 123
  • 6.31 Oct 25, 2016: Utah Medical Products Reports Financial Performance for Third Quarter 2016 124
  • 6.32 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 128
  • 6.33 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 130
  • 6.34 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 133
  • 6.35 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 134
  • 6.36 Oct 18, 2016: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge 136
  • 6.37 Oct 18, 2016: Getinge Interim Report January-September 2016 136
  • 6.38 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 139
  • 6.39 Oct 13, 2016: Vigmed Signs Distribution Agreement For The Important Markets In The United Kingdom And Ireland 139
  • 6.40 Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products 140
  • 6.41 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 140
  • 6.42 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 141
  • 6.43 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit 142
  • 6.44 Sep 15, 2016: STENTYS Reports 2016 First-Half Results 142
  • 6.45 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 143
  • 6.46 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 144
  • 6.47 Aug 30, 2016: MPSC Announces 2016 Interim Results 144
  • 6.48 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 146
  • 6.49 Aug 25, 2016: Interim Report Vigmed Holding January - June 2016 148
  • 6.50 Aug 22, 2016: Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group 149
  • 6.51 Aug 22, 2016: Joacim Lindoff appointed Acting President & CEO of Getinge Group 149
  • 6.52 Aug 16, 2016: Cardiovascular Systems Names Scott Ward as CEO 150
  • 6.53 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 150
  • 6.54 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 153
  • 6.55 Aug 04, 2016: Osprey Medical to Raise USD0.8 Million in Share Purchase Plan of CDIs 153
  • 6.56 Aug 03, 2016: Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results 154
  • 6.57 Aug 03, 2016: U.S. Stem Cell Reports Positive Results for Q2 2016 155
  • 6.58 Aug 02, 2016: Endologix Reports Results for the Second Quarter 2016 156
  • 6.59 Jul 28, 2016: Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million 157
  • 6.60 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 158
  • 6.61 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 159
  • 6.62 Jul 28, 2016: Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year 161
  • 6.63 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 161
  • 6.64 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 162
  • 6.65 Jul 27, 2016: AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters 163
  • 6.66 Jul 26, 2016: Merit Medical Announces Appointment of New Director 163
  • 6.67 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 163
  • 6.68 Jul 26, 2016: Bard Announces Second Quarter Results 165
  • 6.69 Jul 26, 2016: Utah Medical Products Reports Financial Performance for Second Quarter 2016 165
  • 6.70 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 169
  • 6.71 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 170
  • 6.72 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 173
  • 6.73 Jul 22, 2016: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions): Class I Recall - Tip Separation 173
  • 6.74 Jul 21, 2016: Stryker reports second quarter 2016 results 173
  • 6.75 Jul 21, 2016: Federal Circuit Court Rules in Appeal 175
  • 6.76 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 175
  • 6.77 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 177
  • 6.78 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 179
  • 6.79 Jul 14, 2016: Getinge Interim Report January-June 2016 181
  • 6.80 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 181
  • 6.81 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 181
  • 6.82 Jul 12, 2016: STENTYS: 41% Increase in Revenues in the Second Quarter of 2016 182
  • 6.83 Jul 12, 2016: McShane Construction Company Marks Significant Progress at New 630,000 S.F. Medical Supplies Distribution Center in Phoenix, Arizona 183
  • 6.84 Jul 08, 2016: Reed Construction Selected To Complete New Medline Headquarters 183
  • 6.85 Jul 07, 2016: Osprey Medical: Key Sales Milestones 184
  • 6.86 Jul 06, 2016: Cardiovascular Systems Submits Diamondback 360 Coronary Orbital Atherectomy System Micro Crown for Approval in Japan 185
  • 6.87 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 185
  • 6.88 Jul 04, 2016: STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO 186

7 Appendix 249

  • 7.1 Methodology 249
  • 7.2 About GlobalData 252
  • 7.3 Contact Us 252
  • 7.4 Disclaimer 252

List of Tables

  • Table 1: Cardiac Catheters - Pipeline Products by Stage of Development 15
  • Table 2: Cardiac Catheters - Pipeline Products by Segment 16
  • Table 3: Cardiac Catheters - Pipeline Products by Territory 17
  • Table 4: Cardiac Catheters - Pipeline Products by Regulatory Path 18
  • Table 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 19
  • Table 6: Cardiac Catheters - Ongoing Clinical Trials 20
  • Table 7: Cardiac Catheters Companies - Pipeline Products by Stage of Development 21
  • Table 8: Cardiac Catheters - Pipeline Products by Stage of Development 23
  • Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 10: Sizing Valvuloplasty Conductance Balloon Catheter - Product Status 25
  • Table 11: Sizing Valvuloplasty Conductance Balloon Catheter - Product Description 25
  • Table 12: AccuTherm Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 13: Thermal Sensing System - Product Status 26
  • Table 14: Thermal Sensing System - Product Description 26
  • Table 15: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 16: Ultrasonic Catheter - Cardiac Catheterization - Product Status 27
  • Table 17: Ultrasonic Catheter - Cardiac Catheterization - Product Description 27
  • Table 18: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 19: Coronary Angio Catheter - Product Status 28
  • Table 20: Coronary Angio Catheter - Product Description 29
  • Table 21: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 22: Specialty Coronary Catheter - Product Status 30
  • Table 23: Specialty Coronary Catheter - Product Description 30
  • Table 24: Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 25: PrecisionThread - Product Status 31
  • Table 26: PrecisionThread - Product Description 31
  • Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 28: Crossing Catheter - Product Status 32
  • Table 29: Crossing Catheter - Product Description 33
  • Table 30: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 31: Viper Catheter - Product Status 34
  • Table 32: Viper Catheter - Product Description 34
  • Table 33: Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 34: Micro-Loop Catheter - Product Status 35
  • Table 35: Micro-Loop Catheter - Product Description 35
  • Table 36: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 37: Diamondback 360 Coronary OAS Micro Crown - Product Status 36
  • Table 38: Diamondback 360 Coronary OAS Micro Crown - Product Description 37
  • Table 39: Diamondback 360 Coronary Orbital Atherectomy System - Product Status 37
  • Table 40: Diamondback 360 Coronary Orbital Atherectomy System - Product Description 38
  • Table 41: Cardiovascular Systems Inc - Ongoing Clinical Trials Overview 39
  • Table 42: Diamondback 360 Coronary Orbital Atherectomy System - Comparison of CSI's Diamondback 360 Coronary Orbital Atherectomy System (OAS) Versus Conventional Angioplasty (ECLIPSE trial) 40
  • Table 43: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 44: NOGA Guided Myostar Injection Catheter - Product Status 41
  • Table 45: NOGA Guided Myostar Injection Catheter - Product Description 41
  • Table 46: Cordis Corp - Ongoing Clinical Trials Overview 42
  • Table 47: NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction 43
  • Table 48: CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 49: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status 44
  • Table 50: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description 45
  • Table 51: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status 45
  • Table 52: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description 45
  • Table 53: FiberHalo SRM Stent Delivery Catheter - Product Status 46
  • Table 54: FiberHalo SRM Stent Delivery Catheter - Product Description 46
  • Table 55: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 56: Multi-Steerable Catheter - Product Status 47
  • Table 57: Multi-Steerable Catheter - Product Description 48
  • Table 58: Multifunctional Catheter - CTO - Product Status 48
  • Table 59: Multifunctional Catheter - CTO - Product Description 48
  • Table 60: Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 61: Laparoscopic Braided Sealer And Filler Catheter - Product Status 49
  • Table 62: Laparoscopic Braided Sealer And Filler Catheter - Product Description 49
  • Table 63: EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 64: ENABLER-C Catheter System - Product Status 50
  • Table 65: ENABLER-C Catheter System - Product Description 50
  • Table 66: EndoCross Ltd. - Ongoing Clinical Trials Overview 51
  • Table 67: ENABLER-C Catheter System - The ENABLER 3C Study Is Investigating The Safety And Efficacy Of The ENABLER-C Catheter System In Facilitating Guidewire Advancement Through Chronic Total Occlusions In The Coronary Arteries 52
  • Table 68: EP Limited Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 69: Laser Based Thermodilution Catheter - Product Status 53
  • Table 70: Laser Based Thermodilution Catheter - Product Description 53
  • Table 71: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 72: MRI Catheter - Product Status 54
  • Table 73: MRI Catheter - Product Description 55
  • Table 74: Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 75: Double Lumen PCI Guiding Catheter - Product Status 56
  • Table 76: Double Lumen PCI Guiding Catheter - Product Description 56
  • Table 77: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 78: Motion Compensated Catheter System - Product Status 57
  • Table 79: Motion Compensated Catheter System - Product Description 58
  • Table 80: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 81: MaRVis Catheter - Product Status 59
  • Table 82: MaRVis Catheter - Product Description 59
  • Table 83: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 84: Acoustic Catheter - Product Status 60
  • Table 85: Acoustic Catheter - Product Description 60
  • Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 87: Aortic Valve Guide Catheter - Product Status 61
  • Table 88: Aortic Valve Guide Catheter - Product Description 61
  • Table 89: Medeon Biodesign, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 90: IVC-C01 - Product Status 62
  • Table 91: IVC-C01 - Product Description 62
  • Table 92: Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 93: Cardiac/Carotid Aspirating Balloon Catheter - Product Status 63
  • Table 94: Cardiac/Carotid Aspirating Balloon Catheter - Product Description 63
  • Table 95: Ostial Stent Placement Catheter - Product Status 64
  • Table 96: Ostial Stent Placement Catheter - Product Description 64
  • Table 97: Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 98: I - Works - Product Status 65
  • Table 99: I - Works - Product Description 66
  • Table 100: Seiha - Product Status 66
  • Table 101: Seiha - Product Description 66
  • Table 102: Works - Product Status 67
  • Table 103: Works - Product Description 67
  • Table 104: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 105: Dxterity Diagnostic Catheter - Product Status 68
  • Table 106: Dxterity Diagnostic Catheter - Product Description 69
  • Table 107: Low Profile FFR Micro-catheter - Product Status 69
  • Table 108: Low Profile FFR Micro-catheter - Product Description 69
  • Table 109: Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 110: Crossing Support Guide Catheter - Product Status 70
  • Table 111: Crossing Support Guide Catheter - Product Description 71
  • Table 112: Lamsano - Product Status 71
  • Table 113: Lamsano - Product Description 71
  • Table 114: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 115: Catheter - Coronary Ischemia - Product Status 72
  • Table 116: Catheter - Coronary Ischemia - Product Description 73
  • Table 117: Intramyocardial Injection Catheter - Product Status 73
  • Table 118: Intramyocardial Injection Catheter - Product Description 73
  • Table 119: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 120: Ostial Flare - Product Status 74
  • Table 121: Ostial Flare - Product Description 74
  • Table 122: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 123: NesStent's catheter - Product Status 75
  • Table 124: NesStent's catheter - Product Description 75
  • Table 125: NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 126: Catheter - Carotid Stenting - Product Status 76
  • Table 127: Catheter - Carotid Stenting - Product Description 76
  • Table 128: DVT Intervention System - Product Status 77
  • Table 129: DVT Intervention System - Product Description 77
  • Table 130: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 131: Triple Balloon Occlusion/ Infusion Catheter - Product Status 78
  • Table 132: Triple Balloon Occlusion/ Infusion Catheter - Product Description 78
  • Table 133: Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 134: Intravascular Catheter - Chronic Disease - Product Status 79
  • Table 135: Intravascular Catheter - Chronic Disease - Product Description 79
  • Table 136: Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 137: LeafLex - Product Status 80
  • Table 138: LeafLex - Product Description 81
  • Table 139: Second Generation Leaflex Performer Catheter - Product Status 81
  • Table 140: Second Generation Leaflex Performer Catheter - Product Description 81
  • Table 141: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 142: Biodegradable Catheter - Product Status 82
  • Table 143: Biodegradable Catheter - Product Description 82
  • Table 144: Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 145: Cardiovascular Catheter - Gene Therapy - Product Status 83
  • Table 146: Cardiovascular Catheter - Gene Therapy - Product Description 83
  • Table 147: Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 148: Percutaneous Ultrasonic Drug Delivery System - Product Status 84
  • Table 149: Percutaneous Ultrasonic Drug Delivery System - Product Description 84
  • Table 150: Therix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 151: Cardiac Diagnostic Catheter - Product Status 85
  • Table 152: Cardiac Diagnostic Catheter - Product Description 85
  • Table 153: Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 154: IntraVascular MRI catheter - Product Status 86
  • Table 155: IntraVascular MRI catheter - Product Description 87
  • Table 156: TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 157: EndoCardiac Navigator - Product Status 88
  • Table 158: EndoCardiac Navigator - Product Description 88
  • Table 159: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 160: MyoCath - Product Status 89
  • Table 161: MyoCath - Product Description 90
  • Table 162: MyoCath II - Product Status 90
  • Table 163: MyoCath II - Product Description 90
  • Table 164: Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 165: Multifunction Catheter - Product Status 91
  • Table 166: Multifunction Catheter - Product Description 91
  • Table 167: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 168: Cardiac Catheter - Product Status 92
  • Table 169: Cardiac Catheter - Product Description 93
  • Table 170: Delivery Catheter - Product Status 93
  • Table 171: Delivery Catheter - Product Description 93
  • Table 172: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 173: Pre-Hydrate Catheter - Product Status 94
  • Table 174: Pre-Hydrate Catheter - Product Description 94
  • Table 175: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 176: Integrated Dual Lumen Catheter - Product Status 95
  • Table 177: Integrated Dual Lumen Catheter - Product Description 95
  • Table 178: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 179: Preview - Product Status 96
  • Table 180: Preview - Product Description 96
  • Table 181: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 182: IRIS Transseptal Catheter - Product Status 97
  • Table 183: IRIS Transseptal Catheter - Product Description 97
  • Table 184: Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 98
  • Table 185: Zone Isolation and Bypass System - Product Status 98
  • Table 186: Zone Isolation and Bypass System - Product Description 98
  • Table 187: Glossary 250

List of Figures

  • Figure 1: Cardiac Catheters - Pipeline Products by Stage of Development 15
  • Figure 2: Cardiac Catheters - Pipeline Products by Segment 16
  • Figure 3: Cardiac Catheters - Pipeline Products by Territory 17
  • Figure 4: Cardiac Catheters - Pipeline Products by Regulatory Path 18
  • Figure 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 19
  • Figure 6: Cardiac Catheters - Ongoing Clinical Trials 20
Back to Top